New York State Common Retirement Fund’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-200,476
| Closed | -$34.5M | – | 3389 |
|
|
2021
Q3 | $34.5M | Sell |
200,476
-88,110
| -31% | -$11.5M | 0.04% | 436 |
|
|
2021
Q2 | $36.2M | Sell |
288,586
-1,400
| -0.5% | -$177K | 0.04% | 434 |
|
|
2021
Q1 | $39.3M | Buy |
289,986
+2,825
| +1% | +$365K | 0.04% | 386 |
|
|
2020
Q4 | $36.7M | Sell |
287,161
-13,624
| -5% | -$1.6M | 0.04% | 411 |
|
|
2020
Q3 | $33.8M | Buy |
300,785
+66,115
| +28% | +$6.58M | 0.04% | 401 |
|
|
2020
Q2 | $22.4M | Buy |
234,670
+91,257
| +64% | +$8.8M | 0.03% | 541 |
|
|
2020
Q1 | $12.9M | Sell |
143,413
-51,320
| -26% | -$3.99M | 0.02% | 684 |
|
|
2019
Q4 | $10.3M | Sell |
194,733
-8,100
| -4% | -$369K | 0.01% | 948 |
|
|
2019
Q3 | $8.01M | Buy |
202,833
+14,919
| +8% | +$647K | 0.01% | 1036 |
|
|
2019
Q2 | $7.72M | Buy |
187,914
+21,391
| +13% | +$886K | 0.01% | 1090 |
|
|
2019
Q1 | $7.75M | Buy |
166,523
+19,475
| +13% | +$855K | 0.01% | 1061 |
|
|
2018
Q4 | $6.4M | Sell |
147,048
-4,857
| -3% | -$243K | 0.01% | 1076 |
|
|
2018
Q3 | $8.69M | Buy |
151,905
+14,792
| +11% | +$727K | 0.01% | 1069 |
|
|
2018
Q2 | $6.65M | Buy |
137,113
+11,946
| +10% | +$435K | 0.01% | 1158 |
|
|
2018
Q1 | $4.89M | Buy |
125,167
+4,300
| +4% | +$183K | 0.01% | 1241 |
|
|
2017
Q4 | $5.13M | Buy |
120,867
+11,521
| +11% | +$432K | 0.01% | 1238 |
|
|
2017
Q3 | $4.08M | Buy |
109,346
+75,046
| +219% | +$2.61M | 0.01% | 1304 |
|
|
2017
Q2 | $1.04M | Buy |
34,300
+3,599
| +12% | +$104K | ﹤0.01% | 2017 |
|
|
2017
Q1 | $813K | Buy |
30,701
+1
| +0% | +$26 | ﹤0.01% | 2143 |
|
|
2016
Q4 | $783K | Hold |
30,700
| – | – | ﹤0.01% | 2164 |
|
|
2016
Q3 | $1.11M | Buy |
30,700
+6,500
| +27% | +$215K | ﹤0.01% | 1953 |
|
|
2016
Q2 | $822K | Hold |
24,200
| – | – | ﹤0.01% | 2060 |
|
|
2016
Q1 | $639K | Buy |
24,200
+2,200
| +10% | +$64K | ﹤0.01% | 2153 |
|
|
2015
Q4 | $1.07M | Buy |
22,000
+1,200
| +6% | +$43.2K | ﹤0.01% | 1929 |
|
|
2015
Q3 | $518K | Buy |
20,800
+310
| +2% | +$9.32K | ﹤0.01% | 2303 |
|
|
2015
Q2 | $648K | Buy |
+20,490
| New | +$661K | ﹤0.01% | 2404 |
|
New York State Common Retirement Fund's XLRN Position: Q4 2021 in Review
New York State Common Retirement Fund sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 200,476 shares — an estimated $34.5M sold.
New York State Common Retirement Fund first reported a position in XLRN in Q2 2015 and held it in 26 quarters. The position peaked at $39.3M in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- New York State Common Retirement Fund reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- New York State Common Retirement Fund sold 200,476 Acceleron Pharma shares in Q4 2021, an estimated $34.5M.
- New York State Common Retirement Fund first reported a position in Acceleron Pharma in Q2 2015 and held it in 26 quarters.
- New York State Common Retirement Fund's Acceleron Pharma position peaked at $39.3M in Q1 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on New York State Common Retirement Fund's 13F filing for Q4 2021, filed 2 Feb 2022.